{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:48:12Z","timestamp":1765806492621},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experientia"],"published-print":{"date-parts":[[1996,1]]},"DOI":"10.1007\/bf01922409","type":"journal-article","created":{"date-parts":[[2005,7,30]],"date-time":"2005-07-30T15:57:55Z","timestamp":1122739075000},"page":"5-13","source":"Crossref","is-referenced-by-count":95,"title":["The history of cyclosporin A (Sandimmune\u00ae) revisited: Another point of view"],"prefix":"10.1007","volume":"52","author":[{"given":"H. F.","family":"St\u00e4helin","sequence":"first","affiliation":[]}],"member":"297","reference":[{"key":"BF01922409_CR1","doi-asserted-by":"crossref","unstructured":"Aldridge, D. C., Armstrong, J. J., Speake, R. N., and Turner, W. B., The cytochalasins, a new class of biologically active mould metabolites. Chem. Commun. (1967) 26\u201327.","DOI":"10.1039\/c19670000026"},{"key":"BF01922409_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01968693","volume":"1","author":"S. Arrenbrecht","year":"1970","unstructured":"Arrenbrecht, S., and Lazary, S., Effect of the immunosuppressive agent ovalicin on the kinetics of antibody formation. Agents and Actions1 (1970) 221\u2013226.","journal-title":"Agents and Actions"},{"key":"BF01922409_CR3","unstructured":"B\u00e4umler, E.: Die grossen Medikamente. L\u00fcbbe, Bergisch Gladbach 1992."},{"key":"BF01922409_CR4","first-page":"1","volume":"38","author":"J. Bernard","year":"1986","unstructured":"Bernard, J., Ciclosporin: Foreword. Prog. Allergy38 (1986) 1\u20138.","journal-title":"Prog. Allergy"},{"key":"BF01922409_CR5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hlca.19730560303","volume":"56","author":"P. Bollinger","year":"1973","unstructured":"Bollinger, P., Sigg, H. P., and Weber, H. P., Die Struktur von Ovalicin. Hely. chim. Acta56 (1973) 819\u2013830.","journal-title":"Hely. chim. Acta"},{"key":"BF01922409_CR6","first-page":"631","volume":"31","author":"J. F. Borel","year":"1976","unstructured":"Borel, J. F., Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity. Immunology31 (1976) 631\u2013641.","journal-title":"Immunology"},{"key":"BF01922409_CR7","first-page":"5","volume-title":"Cyclosporin A","author":"J. F. Borel","year":"1982","unstructured":"Borel, J. F., The history of cyclosporin A and its significance, in: Cyclosporin A, pp. 5\u201317. Ed. D. J. G. White. Elsevier, Oxford 1982."},{"key":"BF01922409_CR8","unstructured":"Borel, J. F., Address at the presentation of the Prix Galien of France, published in Press Folder of Sandoz Basel, May 1984."},{"key":"BF01922409_CR9","volume-title":"Interview published in the brochure","author":"J. F. Borel","year":"1984","unstructured":"Borel, J. F., Interview published in the brochure \u201cSandimmune\u201d of Laboratories Sandoz, France, 1984."},{"key":"BF01922409_CR10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01973261","volume":"6","author":"J. F. Borel","year":"1976","unstructured":"Borel, J. F., Feurer, C., Gubler, H. U., and St\u00e4helin, H., Biological effects of cyclosporin A: a new antilymphocytic agent. Agents and Actions6 (1976) 468\u2013475.","journal-title":"Agents and Actions"},{"key":"BF01922409_CR11","first-page":"1017","volume":"32","author":"J. F. Borel","year":"1977","unstructured":"Borel, J. F., Feurer, C., Magn\u00e9e, C., and St\u00e4helin, H., Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology32 (1977) 1017\u20131025.","journal-title":"Immunology"},{"key":"BF01922409_CR12","first-page":"1867","volume":"23","author":"J. F. Borel","year":"1991","unstructured":"Borel, J. F., Kis, Z. L., The discovery and development of cyclosporine (Sandimmune). Transplant. Proc.23 (1991) 1867\u20131874.","journal-title":"Transplant. Proc."},{"key":"BF01922409_CR13","first-page":"777","volume":"32","author":"J. F. Borel","year":"1976","unstructured":"Borel, J. F., R\u00fcegger, A., and St\u00e4helin, H., Cyclosporin A: a new antilymphocytic agent. Experientia32 (1976) 777.","journal-title":"Experientia"},{"key":"BF01922409_CR14","first-page":"26","volume-title":"Ces m\u00e9dicaments qui ont chang\u00e9 la vie. Chapitre 3","author":"F. Bridel","year":"1985","unstructured":"Bridel, F., Ces m\u00e9dicaments qui ont chang\u00e9 la vie. Chapitre 3, pp. 26\u201338. Payot, Lausanne 1985."},{"key":"BF01922409_CR15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF01982474","volume":"11","author":"E. Bueding","year":"1981","unstructured":"Bueding, E., Hawkins, J. and Cha, Y.-N., Antischistosomal effects of cyclosporin A. Agents and Actions11 (1981) 380\u2013383.","journal-title":"Agents and Actions"},{"key":"BF01922409_CR16","first-page":"1","volume":"1","author":"R. Y. Calne","year":"1984","unstructured":"Calne, R. Y., The development of immunosuppression in organ transplantation. Progr. Transplant.1 (1984) 1\u201310.","journal-title":"Progr. Transplant."},{"key":"BF01922409_CR17","first-page":"595","volume":"5","author":"R. Y. Calne","year":"1977","unstructured":"Calne, R. Y., and White, D. J. G., cyclosporin A \u2014 a powerful immunosuppressant in dogs with renal allografts. IRCS med. Sci.5 (1977) 595.","journal-title":"IRCS med. Sci."},{"key":"BF01922409_CR18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(78)90971-6","volume":"I","author":"R. Y. Calne","year":"1978","unstructured":"Calne, R. Y., White, D. J. G., Rolles, K., Smith, D. P., and Herbertson, B. M., Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. LancetI (1978) 1183\u20131185.","journal-title":"Lancet"},{"key":"BF01922409_CR19","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","volume":"II","author":"R. Y. Calne","year":"1978","unstructured":"Calne, R. Y., White, D. J. G., Thiru, S., Evans, D. B., McMaster, P., Dunn, D. C., Craddock, G. N., Pentlow, D. B., and Rolles, K., Cyclosporin A in patients receiving renal allografts from cadaver donors. LancetII (1978) 1323\u20131327.","journal-title":"Lancet"},{"key":"BF01922409_CR20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/213261a0","volume":"213","author":"S. B. Carter","year":"1967","unstructured":"Carter, S. B., Effects of cytochalasins on mammalian cells. Nature, Lond.213 (1967) 261\u2013264.","journal-title":"Nature, Lond."},{"key":"BF01922409_CR21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hlca.19740570306","volume":"57","author":"A. Closse","year":"1974","unstructured":"Closse, A., und Huguenin, R., Isolierung und Strukturaufkl\u00e4rung von Chlamydocin. Helv. chim. Acta57 (1974) 533\u2013545.","journal-title":"Helv. chim. Acta"},{"key":"BF01922409_CR22","doi-asserted-by":"crossref","unstructured":"Dawkins, A. W., Grove, J. F., and Tidd, B. K., Diacetoxyscirpenol and some related compounds. Chem. Commun. (1965) 27\u201328.","DOI":"10.1039\/c19650000027"},{"key":"BF01922409_CR23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00000421-198606000-00002","volume":"9","author":"P. A. DeSimone","year":"1986","unstructured":"DeSimone, P. A., Greco, F. A., Lessner, H. F., and Bartolucci, A., Phase II evaluation of anguidine (NSC 141537) in 5-day courses in colorectal adenocarcinoma. A Southeastern Cancer Study Group trial. Am. J. clin. Oncol.9 (1986) 187\u2013188.","journal-title":"Am. J. clin. Oncol."},{"key":"BF01922409_CR24","first-page":"43","volume-title":"Anticancer agents based on natural product models","author":"T. W. Doyle","year":"1980","unstructured":"Doyle, T. W., and Bradner, W. T., Trichothecanes, in: Anticancer agents based on natural product models, pp. 43\u201372. Eds J. M. Cassady and J. D. Douros. Academic Press, New York 1980."},{"key":"BF01922409_CR25","first-page":"22","volume":"39","author":"M. Dreyfuss","year":"1986","unstructured":"Dreyfuss, M., Neue Erkenntnisse aus dem pharmakologischen Pilz-Screening. Sydowia39 (1986) 22\u201336.","journal-title":"Sydowia"},{"key":"BF01922409_CR26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/B978-0-7506-9003-4.50009-5","volume-title":"The Discovery of Natural Products with Therapeutic Potential","author":"M. Dreyfuss","year":"1994","unstructured":"Dreyfuss, M., and Chapela, I. H., Potential of fungi in the discovery of novel, low-molecular weight pharmaceuticals, in: The Discovery of Natural Products with Therapeutic Potential, pp. 49\u201380. Ed. V. P. Gullo. Butterworth-Heinemann, Boston 1994."},{"key":"BF01922409_CR27","first-page":"125","volume":"3","author":"M. Dreyfuss","year":"1976","unstructured":"Dreyfuss, M., H\u00e4rri, E., Hofmann, H., Kobel, H., Pache, W., and Tscherter, H., Cyclosporin A and C. New metabolites fromTrichoderma polysporum (Link ex pers.) Rifai. Europ. J. appl. Microbiol.3 (1976) 125\u2013133.","journal-title":"Microbiol."},{"key":"BF01922409_CR28","unstructured":"Editorial, Cyclosporin turns five. Science242 (1988) 198."},{"key":"BF01922409_CR29","doi-asserted-by":"crossref","unstructured":"Flury, E., Mauli, R., and Sigg, H. P., The constitution of diacetoxyscirpenol. Chem. Commun. (1965) 26\u201327.","DOI":"10.1039\/c19650000026"},{"key":"BF01922409_CR30","unstructured":"Gorner, P., Wonderworker. Chicago Tribune, Dec. 28, 1988."},{"key":"BF01922409_CR31","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(78)90970-4","volume":"I","author":"C. J. Green","year":"1978","unstructured":"Green, C. J., and Allison, A. C., Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment. The LancetI (1978) 1182\u20131183.","journal-title":"The Lancet"},{"key":"BF01922409_CR32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/hlca.19650480117","volume":"48","author":"J. Gutzwiller","year":"1965","unstructured":"Gutzwiller, J., and Tamm, C., Ueber die Struktur von Verrucarin A. Helv. chim. Acta48 (1965) 157\u2013176.","journal-title":"Helv. chim. Acta"},{"key":"BF01922409_CR33","unstructured":"Haller, M., Der Sandimmun-Krimi: Die Geschichte des Medikamentes, mit dem heute am meisten Geld verdient wird. Weltwoche (Z\u00fcrich) Dec. 3 (1992) 61\u201363; Dec. 10 (1992) 53; Dec. 17 (1992) 47. An English translation by F. Niklaus is available from the author of the present paper."},{"key":"BF01922409_CR34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/hlca.19620450314","volume":"45","author":"E. H\u00e4rri","year":"1962","unstructured":"H\u00e4rri, E., Loeffler W., Sigg, H. P. St\u00e4helin, H., Stoll, Ch., Tamm, Ch., and Wiesinger, D., Ueber die Verrucarine und Roridine, eine Gruppe von cytostatisch hochwirksamen Antibiotica aus Myrothecium-Arten. Helv. chim. Acta45 (1962) 839\u2013853.","journal-title":"Helv. chim. Acta"},{"key":"BF01922409_CR35","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/hlca.19630460419","volume":"46","author":"E. H\u00e4rri","year":"1963","unstructured":"H\u00e4rri, E., Loeffler W., Sigg, H. P., St\u00e4helin, H., and Tamm, Ch., Ueber die Isolierung neuer Stoffwechselprodukte aus Penicillium brefeldianum Dodge. Helv. chim. Acta46 (1963) 1235\u20131243.","journal-title":"Helv. chim. Acta"},{"key":"BF01922409_CR36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-0028-1097447","volume":"34","author":"G. R. Hartmann","year":"1978","unstructured":"Hartmann, G. R., Richter, H., Weiner, E. M., and Zimmermann, W., On the mechanism of action of the cytostatic drug anguidine and of the immunosuppressive agent ovalicin, two sesquiterpenes from fungi. Planta med.34 (1978) 231\u2013252.","journal-title":"Planta med."},{"key":"BF01922409_CR37","first-page":"4","volume":"50","author":"A. Hofmann","year":"1979","unstructured":"Hofmann, A., Planung und Zufall in der pharmazeutischchemisschen Forschung. Sandoz Bulletin50 (1979) 4\u201317.","journal-title":"Sandoz Bulletin"},{"key":"BF01922409_CR38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1126\/science.6407111","volume":"221","author":"G. Kolata","year":"1983","unstructured":"Kolata, G., Drug transforms transplant medicine (Editorial). Science221 (1983) 40\u201342.","journal-title":"Science"},{"key":"BF01922409_CR39","first-page":"280","volume":"5","author":"A. J. Kostakis","year":"1977","unstructured":"Kostakis, A. J., White, D. J. G., and Calne, R. Y., Prolongation of the rat heart allograft survival by cyclosporin A. IRCS med. Sci.5 (1977) 280.","journal-title":"IRCS med. Sci."},{"key":"BF01922409_CR40","first-page":"317","volume-title":"Proc. 5th Internat. Congr. Chemotherapy, (Vienna)","author":"S. Lazary","year":"1967","unstructured":"Lazary S., and St\u00e4helin, H., Immunosuppressive, Wirkung von Podophyllumstoffen und andern Cytostatica, in: Proc. 5th Internat. Congr. Chemotherapy, (Vienna), pp. 317\u2013322. Eds K. H. Spitzy and H. Haschek. Wiener mediz. Akademie. Wien 1967."},{"key":"BF01922409_CR41","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/BF02147835","volume":"24","author":"S. Lazary","year":"1968","unstructured":"Lazary, S., and St\u00e4helin, H., Immunosuppressive and specific antimitotic effects of ovalicin. Experientia24 (1968) 1171\u20131173.","journal-title":"Experientia"},{"key":"BF01922409_CR42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000386780","volume":"15","author":"S. Lazary","year":"1969","unstructured":"Lazary, S., and St\u00e4helin, H., Immunosuppressive effect of a new antibiotic: ovalicin. Antibiotica et Chemother.15 (1969) 177\u2013181.","journal-title":"Antibiotica et Chemother"},{"key":"BF01922409_CR43","first-page":"691","volume":"26","author":"S. Lazary","year":"1970","unstructured":"Lazary, S., and St\u00e4helin, H., Ovalicin and other drugs in experimental allergic encephalomyelitis (EAE). Experientia26 (1970) 691.","journal-title":"Experientia"},{"key":"BF01922409_CR44","first-page":"1485","volume":"66","author":"C. J. Mirocha","year":"1983","unstructured":"Mirocha, C. J., Pawlowsky, R. A., Chatterjee, K., Watson, S., and Hayes, W., Analysis of Fusarium toxins in various samples implicated in biological warfare in Southeast Asia. J. Ass. off. analyt. Chem.66 (1983) 1485\u20131499.","journal-title":"J. Ass. off. analyt. Chem."},{"key":"BF01922409_CR45","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1016\/S0021-9258(18)67398-3","volume":"261","author":"Y. Misumi","year":"1986","unstructured":"Misumi, Y., Misumi, Y., Miki, K., Takatsuki, A., Tamura, G., and Ikehara, Y., Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J. biol. Chem.261 (1986) 11398\u201311403.","journal-title":"J. biol. Chem."},{"key":"BF01922409_CR46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0378-4274(88)90057-4","volume":"41","author":"J. J. Pestka","year":"1988","unstructured":"Pestka, J. J., and Forsell, J. H., Inhibition of human lymphocyte transformation by the macrocyclic trichothecenes roridin A and verrucarin A. Toxic. Lett.41 (1988) 215\u2013222.","journal-title":"Toxic. Lett."},{"key":"BF01922409_CR47","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/hlca.19760590509","volume":"59","author":"T. J. Petcher","year":"1976","unstructured":"Petcher, T. J., Weber, H. P., and R\u00fcegger., A., Crystal and molecular structure of an iodo-derivative of the cyclic undecapeptide cyclosporin A. Helv. chim. Acta59 (1976) 1480\u20131488.","journal-title":"Helv. chim. Acta"},{"key":"BF01922409_CR48","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0140-6736(78)91971-2","volume":"II","author":"R. L. Powles","year":"1978","unstructured":"Powles, R. L., Barrett, A. J., Clink, H., Kay, H. E. M., Sloane, J., and McElwain, T. J., Cyclosporin A for the treatment of graft-versus-host disease in man. LancetII (1978) 1327\u20131331.","journal-title":"Lancet"},{"key":"BF01922409_CR49","volume-title":"Bioburst: The Impact of Modern Biology on the Affairs of Man","author":"R. N. Re","year":"1986","unstructured":"Re, R. N., Bioburst: The Impact of Modern Biology on the Affairs of Man. Louisiana State Univ. Press, Baton Rouge 1986."},{"key":"BF01922409_CR50","volume-title":"Serendipity","author":"R. M. Roberts","year":"1989","unstructured":"Roberts, R. M., Serendipity. Wiley, New York 1989."},{"key":"BF01922409_CR51","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/BF01901360","volume":"22","author":"W. Rothweiler","year":"1966","unstructured":"Rothweiler, W., and Tamm, Ch., Isolation and structure of phomin. Experientia22 (1966) 750\u2013752.","journal-title":"Experientia"},{"key":"BF01922409_CR52","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/hlca.19760590412","volume":"59","author":"A. R\u00fcegger","year":"1976","unstructured":"R\u00fcegger, A., Kuhn, M., Lichti, H., Loosli, H. R., Huguenin, R., Quiquerez, C. and von Wartburg, A., Cyclosporin A, ein imunosuppressiv wirksamer, Peptidmetabolit ausTrichoderma polysporum (Link ex Pers.) Rifai. Helv. chim. Acta59 (1976) 1075\u20131092.","journal-title":"Helv. chim. Acta"},{"key":"BF01922409_CR53","first-page":"893","volume":"15","author":"M. E. R\u00fcsch","year":"1965","unstructured":"R\u00fcsch, M. E., and St\u00e4helin, H., Ueber einige biologische Wirkungen des Cytostaticum Verrucarin A. Arzneimittelforsch. (Drug Research)15 (1965) 893\u2013897.","journal-title":"Arzneimittelforsch. (Drug Research)"},{"key":"BF01922409_CR54","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.139.6.1797","volume":"139","author":"S. Sawada","year":"1987","unstructured":"Sawada, S., Suzuki, G., Kawase, Y., and Takaku, F., Novel immunosuppressive agent, FK 506. In vitro effects on the cloned T cell activation. J. Immun.139 (1987) 1797\u20131803.","journal-title":"J. Immun."},{"key":"BF01922409_CR55","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/hlca.19640470603","volume":"47","author":"H. P. Sigg","year":"1964","unstructured":"Sigg, H. P., Die Konstitution von Brefeldin A. Helv. chim. Acta47 (1964) 1401\u20131415.","journal-title":"Helv. chim. Acta"},{"key":"BF01922409_CR56","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hlca.19650480434","volume":"48","author":"H. P. Sigg","year":"1965","unstructured":"Sigg, H. P., Mauli, R., Flury, E., and Hauser, D., Die Konstitution von Diacetoxyscirpenol. Helv. chim. Acta48 (1965) 962\u2013988.","journal-title":"Helv. chim. Acta"},{"key":"BF01922409_CR57","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/hlca.19680510624","volume":"51","author":"H. P. Sigg","year":"1968","unstructured":"Sigg, H. P., and Weber, H. P., Isolierung und Strukturaufkl\u00e4rung von Ovalicin. Helv. chim. Acta.51 (1968) 1395\u20131408.","journal-title":"Helv. chim. Acta."},{"key":"BF01922409_CR58","first-page":"301","volume":"17","author":"N. J. Souza de","year":"1982","unstructured":"de Souza, N. J., Ganguli, B. N., and Reden, J., Strategies in the discovery of drugs from natural sources. Ann. Rep. med. Chem17 (1982) 301\u2013310.","journal-title":"Ann. Rep. med. Chem"},{"key":"BF01922409_CR59","first-page":"296","volume":"17","author":"H. St\u00e4helin","year":"1954","unstructured":"St\u00e4helin, H., Ueber osmotisches Verhalten und Fusion nackter Protoplasten von Bac. anthracis. Schweiz. Zs. allg. Path. Bakt.17 (1954) 296\u2013310.","journal-title":"Zs. allg. Path. Bakt."},{"key":"BF01922409_CR60","unstructured":"St\u00e4helin, H., Internal Report, Sandoz Pharma of July 13, 1959, on compound No. 9648 (phomin, cytochalasin B)."},{"key":"BF01922409_CR61","unstructured":"St\u00e4helin, H., Internal Report Sandoz Pharma of October 6, 1960, on compound No. 11-247 (HPS 277, brefeldin A)."},{"key":"BF01922409_CR62","first-page":"92","volume":"7","author":"H. St\u00e4helin","year":"1962","unstructured":"St\u00e4helin, H., A simple quantitative test for cytostatic agents using non-adhering cells in vitro. Med. exp.7 (1962) 92\u2013102.","journal-title":"Med. exp."},{"key":"BF01922409_CR63","unstructured":"St\u00e4helin, H., Internal Report Sandoz Pharma of November 18, 1964, on compounds No. 7827 and 11-699\/2."},{"key":"BF01922409_CR64","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2964(70)90095-2","volume":"6","author":"H. St\u00e4helin","year":"1970","unstructured":"St\u00e4helin, H., 4\u2032-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action. Europ. J. Cancer6 (1970) 303\u2013311.","journal-title":"Europ. J. Cancer"},{"key":"BF01922409_CR65","first-page":"19","volume":"38","author":"H. St\u00e4helin","year":"1986","unstructured":"St\u00e4helin, H., Ciclosporin: Historical background. Prog. Allergy38 (1986) 19\u201327.","journal-title":"Prog. Allergy"},{"key":"BF01922409_CR66","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF01953314","volume":"44","author":"H. St\u00e4helin","year":"1988","unstructured":"St\u00e4helin, H., Enhanced toxicity of the immunosuppressant ovalicin upon application to the skin. Experientia44 (1988) 611\u2013613.","journal-title":"Experientia"},{"key":"BF01922409_CR67","first-page":"185","volume-title":"Immunology 1930\u20131980, Essays on the History of Immunology","author":"H. St\u00e4helin","year":"1989","unstructured":"St\u00e4helin, H., The development of immunosuppressive agents from x-rays to cyclosporin, in: Immunology 1930\u20131980, Essays on the History of Immunology, pp. 185\u2013201. Ed. P. M. H. Mazumdar. Wall and Thompson, Toronto 1989."},{"key":"BF01922409_CR68","first-page":"1490","volume":"94","author":"H. St\u00e4helin","year":"1964","unstructured":"St\u00e4helin, H., and Cerletti, A., Experimentelle Ergebnisse mit den Podophyllum-Cytostatica SP-I und SP-G. Schweiz. med. Wschr.94 (1964) 1490\u20131502.","journal-title":"med. Wschr."},{"key":"BF01922409_CR69","first-page":"989","volume":"18","author":"H. St\u00e4helin","year":"1968","unstructured":"St\u00e4helin, H., Kalberer-R\u00fcsch, M. E., Signer, E., und Lazary, S., Ueber einige biologische Wirkungen des Cytostaticum Diacetoxyscirpenol. Arzneimittelforsch. (Drug Research)18 (1968) 989\u2013994.","journal-title":"Arzneimittelforsch. (Drug Research)"},{"key":"BF01922409_CR70","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1084\/jem.105.3.265","volume":"105","author":"H. St\u00e4helin","year":"1957","unstructured":"St\u00e4helin, H., Karnovsky, M. L., Farnham, A. E., and Suter, E., Studies on the interaction between phagocytes and tubercle bacilli. III. Some metabolic effects in guinea pigs associated with infection with tubercle bacilli. J. exp. Med.105 (1957) 265\u2013277.","journal-title":"J. exp. Med."},{"key":"BF01922409_CR71","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0014-2964(74)90137-6","volume":"10","author":"H. St\u00e4helin","year":"1974","unstructured":"St\u00e4helin, H., and Trippmacher, A., Cytostatic activity of chlamydocin, a rapidly inactivated cyclic tetrapeptide. Europ. J. Cancer10 (1974) 801\u2013808.","journal-title":"Europ. J. Cancer"},{"key":"BF01922409_CR72","first-page":"5","volume":"51","author":"H. St\u00e4helin","year":"1991","unstructured":"St\u00e4helin, H., and von Wartburg, A. The chemical and biological route from podophyllotoxin glucoside to etoposide: ninth Cain Memorial Award Lecture. Cancer Res.51 (1991) 5\u201315.","journal-title":"Cancer Res."},{"key":"BF01922409_CR73","first-page":"63","volume":"31","author":"Ch. Tamm","year":"1974","unstructured":"Tamm, Ch., The antibiotic complex of the verrucarins and roridins. Fortschr. Chem. Org. Naturst.31 (1974) 63\u2013117.","journal-title":"Fortschr. Chem. Org. Naturst."},{"key":"BF01922409_CR74","doi-asserted-by":"crossref","first-page":"160","DOI":"10.7164\/antibiotics.21.160","volume":"21","author":"G. Tamura","year":"1968","unstructured":"Tamura, G., Ando, K., Suzuki, S., Takatsuki, A., and Arima, K., Antiviral activity of brefeldin A and verrucarin A. J. Antibiotic.21 (1968) 160\u2013161.","journal-title":"J. Antibiotic."},{"key":"BF01922409_CR75","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/BF01978803","volume":"11","author":"K. Thommen","year":"1981","unstructured":"Thommen, K., Antimalarial activity of cyclosporin A. Agents and Actions11 (1981) 770\u2013773.","journal-title":"Agents and Actions"},{"key":"BF01922409_CR76","unstructured":"Thompson, L., Jean-Fran\u00e7ois Borel's transplanted dream. Washington Post, November 15, 1988."},{"key":"BF01922409_CR77","unstructured":"Traxler, R., In der Pharma-Forschung beginnt die Zukunft in der Vergangenheit. Nordschweiz, September 23, 1988."},{"key":"BF01922409_CR78","unstructured":"Weiner, E., Ueber die immunosuppressive Wirkung des Sesquiterpens Ovalicin auf Lymphozyten. Thesis, Univ. of W\u00fcrzburg 1976."},{"key":"BF01922409_CR79","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-065X.1982.tb00430.x","volume":"65","author":"D. J. G. White","year":"1982","unstructured":"White, D. J. G., and Calne, R. Y., The use of cyclosporin A immunosuppression in organ grafting. Immun. Rev.65 (1982) 115\u2013131.","journal-title":"Immun. Rev."},{"key":"BF01922409_CR80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.1993.tb17137.x","volume":"696","author":"G. Wiederrecht","year":"1993","unstructured":"Wiederrecht, G., Lam E., Hung, S., Martin, M., and Sigal, N., The mechanism of action of FK-506 and cyclosporin A. Ann. N. Y. Acad. Sci.696 (1993) 9\u201319.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BF01922409_CR81","unstructured":"Wiskott, E., Sandimmun. Internat. Sandoz Gazette, March 1983."},{"key":"BF01922409_CR82","first-page":"569","volume-title":"Cyclosporin A","author":"M. Woodruff","year":"1982","unstructured":"Woodruff, M., Concluding Remarks, in: Cyclosporin A, pp. 569\u2013573. Ed. D. J. G. White. Elsevier, Oxford 1982."},{"key":"BF01922409_CR83","first-page":"109","volume":"40","author":"C. Ypersele de Strihou van","year":"1985","unstructured":"van Ypersele de Strihou, C., La cyclosporine. J. Pharm. Belg.40 (1985) 109\u2013112.","journal-title":"J. Pharm. Belg."}],"container-title":["Experientia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01922409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01922409\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01922409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T22:18:53Z","timestamp":1683152333000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01922409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["BF01922409"],"URL":"https:\/\/doi.org\/10.1007\/bf01922409","relation":{},"ISSN":["0014-4754","1420-9071"],"issn-type":[{"value":"0014-4754","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}